Arterial HypertensionNCT04160533
Registry of Arterial Hypertension
An observational study of Arterial Hypertension, run by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation at 17 sites in Russia.
Trial summary
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Arterial Hypertension
- How many people
- 10,400 participants
- Where
- 17 sitesRussia
- Study dates
- 1 Jun 2018to Dec 2026
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: outpatient patients from 18 to 99 years old with a diagnosis of hypertension
Who may be able to join
None listed.
Who cannot join
- -
Trial locations and contacts
17 sites in 1 country. Contact the study team or a site near you to ask about taking part.
17 sites in 1 country
Russia17 sites, 17 recruiting
- Recruiting
State Healthcare Institution "Engels City Polyclinic No. 2
Engel's
- Recruiting
State Healthcare Institution "Engels City Polyclinic No. 4
Engel's
- Recruiting
State budgetary health institution of the Kemerovo region "Kemerovo Regional Clinical Cardiology Dispensary named after Academician L.S. Barbarash
Kemerovo
- Recruiting
Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation
Moscow, Moscow Oblast, 121552
Анна Аксенова, 89032319955, aksenovaannav@gmail.com
- Recruiting
State budgetary institution of the ryazan region "regional clinical cardiological dispensary"
Ryazan
- Recruiting
Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №1
Taganrog
- Recruiting
Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №2
Taganrog
- Recruiting
Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №3
Taganrog
- Recruiting
Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №4
Taganrog
- Recruiting
Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №1
Taganrog
- Recruiting
Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №4
Taganrog
- Recruiting
Municipal budgetary institution of public health services "City ambulance hospital" city of Taganrog
Taganrog
- Recruiting
State Autonomous Healthcare Institution of the Tyumen Region "Tyumen Institute of Therapy
Tyumen
- Recruiting
Municipal Health Institution "City Hospital No. 1" Volgodonsk
Volgodonsk
- Recruiting
Municipal health institution "City polyclinic №1" Volgodonsk
Volgodonsk
- Recruiting
Municipal health institution "City polyclinic №3" Volgodonsk
Volgodonsk
- Recruiting
State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic
Volgograd
About this study
Official title: Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.
The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.
Read more
The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.
Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.
Read the detailed description
The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension
- Conditions
- Arterial Hypertension
- Medical subject headings
- Hypertension
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of patients with blood pressure <140/90 mm Hg
The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.
Measured: 2018 - 2021 years
Secondary outcomes (2)
Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.
Diagnosis data is entered by doctors as a "yes" or "no" category.
Measured: 2018-2021
Antihypertensive medications
Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages
Measured: 2018-2021
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2019
- Study start1 Jun 2018
- Primary completion1 Dec 2026 (estimated)
- Study completionDec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arterial HypertensionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 10,400 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04160533
- Sponsor's protocol ID
- 86
- Status last verified
- Apr 2026
- First submitted
- 29 Aug 2019
- Last updated
- 13 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"
- ClinicalTrials.gov ID
- NCT04160533
- Acronym / sponsor ID
- 86
- Conditions
- Arterial Hypertension
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 10,400 participants (estimated)
- Lead sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian FederationOther government
- Study start
- 1 Jun 2018 (actual)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- Dec 2026 (estimated)
- First posted
- 13 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.
The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.
The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.
Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.
Detailed description
The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- outpatient patients from 18 to 99 years old with a diagnosis of hypertension
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of patients with blood pressure <140/90 mm Hg
Time frame: 2018 - 2021 years
The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.
2 secondary outcomes
Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.
Time frame: 2018-2021
Antihypertensive medications
Time frame: 2018-2021
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Apr 2026.
Related trials for Arterial Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
17 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arterial Hypertension, run by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation at 17 sites in Russia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 17 sites in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Anna Aksenova, MD (+74954146186, aksenovaannav@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of patients with blood pressure <140/90 mm Hg (time frame: 2018 - 2021 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.